Notelovitz M, Greig H B
J Reprod Med. 1976 Feb;16(2):87-90.
Anti-thrombin III activity was measured in normal pre- and postmenopausal female controls: during late pregnancy, in young women taking oral contraceptives and in postmenopausal women treated with natural, conjugated estrogens. Both the pregnant patients and women on oral contraceptives had significantly lower anti-thrombin III levels when compared with the normal, untreated control group. Treatment with natural estrogens did not result in any alteration in anti-thrombin III activity. There was no significant difference in the anti-thrombin III values in the pre- and postmenopausal control subjects.
在正常绝经前和绝经后女性对照组中测量抗凝血酶III活性:在妊娠晚期、服用口服避孕药的年轻女性以及接受天然共轭雌激素治疗的绝经后女性中进行测量。与正常未治疗的对照组相比,怀孕患者和服用口服避孕药的女性的抗凝血酶III水平显著降低。天然雌激素治疗并未导致抗凝血酶III活性发生任何改变。绝经前和绝经后对照受试者的抗凝血酶III值没有显著差异。